Tuberculosis (TB) still remains an important medical problem due to high levels of morbidity and mortality worldwide. A series of innate immune mechanisms that create a cytokine network control the pathogenesis of tuberculosis and this response has the capacity to modify the host genomic DNA structure through epigenetic mechanisms such as DNA methylation which could constantly alter the local gene expression pattern that can modulate the metabolism of the tissues and the immune-response. Interferongamma (IFN-γ) is an important pro-inflammatory cytokine regulator of the innate immune response to TB. This study aims to determine DNA methylation patterns of INF-γ gene promoter and measure serum IFN-γ level in newly diagnosed TB patients, relapse TB patients, and healthy control, in order to study the possibility of using these as a biomarker for the prognosis of TB stages in patients. The current case-control study included 66 patients with TB and 33 healthy control subjects. DNA was extracted from peripheral blood(PB) of included subjects and modified using sodium bisulfate specific kit. DNA methylation patterns of IFN-γ gene promoter was determine by using methylation specific polymerase chain reaction(MS-PCR).Serum IFN-γ level was determined using enzyme linked immune-sorbent assay(ELISA). Results showed that percentages of DNA methylation patterns in normal controls, newly diagnostic TB patients and relapse TB patients were (63.3%, 18.2% and 21.2% respectively). Also, higher significant differences (P≤0.0001) of un-methylated IFN-γ gene promoter patterns in newly diagnostic TB patients than relapse TB patients comparison with healthy controls. The percentage of un-methylated DNA patterns in healthy controls, newly diagnostic TB patients and relapse TB patients were (9.9%, 39.4% and 51.5%, respectively). The mean of serum IFN-γ levels (pg/ml) for normal controls, newly diagnostic TB patients and relapse TB patients were (59.3± 13.8,75.8±24.3 and 69.6±18.7,respectively).In conclusion, there is a relative association between methylation of IFN-γ gene promoter and predisposing to TB progression.
Introduction:
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis (M. tuberculosis) and it remains one of the world's biggest threats. In 2014, TB killed 1.5 million people (1.1 million HIV-negative and 0.4 million HIV-positive) (1,2). The World Health Organization (WHO) suggested new strategy that set targets for TB elimination for the first time in 2015.
To achieve these ambitious goals, new drugs, new diagnostics methods and vaccines will be needed (3) . Molecular epidemioloical studies referred that the development of active TB was due to reactivation of the original strain that may occur decades after the initial infection (4) . The development of infection from latent TB (LTB) to primery TB (PTB) reflects deficincy of host resistance to M. tuberculosis (5) . There is a strong evidence that the development of LTB is controled by host genetic factors.These genetic factores are likely to be different from these involved in PTB (6) .
During infection with M. tuberculosis, the host innate immune response composes the first defense,then bacteria will be taken up by the reside phagocytic cells in the lungs (7, 8) . Interferongamma (IFN-γ, also known as type II interferon) is Open Access an important immune-regulatory cytokine that was originally identified as an anti-viral agent (9) . It plays a key role in host defense by exerting antiproliferative and immune regulatory activities (8) .The mycobacterial TB has the capacity to alter the host DNA structure through epigenetic mechanisms. Epigenetics is defined as an alteration in conformational structure of DNA without any changes in the sequence that result in making it more or less accessible to transcription process. DNA methylation is considered a major epigenetic alteration in human DNA which change the local gene expression by inducing genomic-epigenetic changes that can affect the metabolism of the tissues and the inflammatory response (10) .
Human immune response such as cytokine production, anti-inflammatory response and cell differentiation regulated by DNA methylation, in addition to genetic control. In eukaryotes, methyl group(CH 3 ) added to the position of carbon number 5 of the cytosine in CpG islands. Un-methylated islands are related with actively transcripted gene, whereas methylated islands can bind with methylbinding proteins that up hold chromatin compaction and avoid the binding of transcription factors to these dinucleotide. Variations in the epigenome, and gene polymorphism of different ethnic groups control host susceptibility to TB infection (11) . This epigenetic alteration may explain the host-pathogen interaction of M. tuberculosis and act as a biomarkers that decide what situation will be latency or disease (12) .
The cytokine networks established by the macrophages in the innate immune response play a critical role in the control of M. tuberculosis infection, but the underlying mechanism for M. tuberculosis infection to induce hyper-methylation of cytokine remains poorly understood (13) .The current study aims to investigate the utility of DNA methylation patterns of INF-γ gene promoter and INF-γ serum level in TB patients, in order to determine the usefulness of these biomarkers as early prognosis tool in pulmonary tuberculosis.
Materials and Methods: Patients
The current case-control study included 66 samples from patients with TB collected during period from April 2016 to April 2017. Also,33 samples from healthy controls were included. Patients age ranged from 16-70years and healthy controls age range from 20-65 years. Peripheral blood samples were collected from enrolled patients whom attend TB Centers in Baghdad, Wasit and AlEmamen Al-Kadhmain Teaching Hospital. Samples from patients(66 samples) and healthy controls (33 samples) were taken from both genders (54 male and 45 female).The subjects included in this study were grouped as following: Group 1: included 33 newly diagnosed patients with active PTB whom did not receive antituberculosis treatment before sampling. Those patients had been re-evaluated after 2 months of anti-TB therapy. Serum IFN-γ level was performed before treatment and after 2 months of patient therapy (rifampicin + isoniazide + ethambutol and pyrazinamide), when their sputum became negative for acid fast bacilli (AFB). Group 2: included 33 relapsed cases of PTB. Those patients had been diagnosed with TB and whom had completed the treatment successfully but was diagnosed with TB again. That was managed by AFB smear positivity in sputum sample or those with both cavitation on initial chest radiography and positive sputum smear after 1-2 years of anti-TB treatment. Group 3: included 33 healthy adults. All healthy volunteers were checked for the chronic and common disease such as diabetes mellitus, renal failure or heart disease and no history or signs of active PTB and also negative for AFB.
Inclusion criteria specified consideration of a TB dataset from any of the following active medical condition will be excluded : HIV infection, nephritic syndrome, enteric fever, viral hepatitis, diabetes mellitus, leprosy, infectious mononucleosis, chronic malnutrition, and Asthma. This study was approved by the ethical committee of the College of Medicine-Al-Nahrain University, Baghdad, Iraq.
Samples
Ten milliliters of venous blood were drawn from each subject and preserved in two tube,(5 ml) in an anti-coagulated tubes containing sodium-EDTA, and (5 ml) in the second plain tube for serum and sera will be separated by centrifugation at 1500xg for 10 min at 4•C, divided into small aliquots and stored at -80•C until used.
Identification of M. tuberculosis in Patient Sputum Sample
Acid-Fast Staining of direct sputum smear was prepared (14) .The smear was examined microscopically by specialist in hospital and center lab, using the 100X oil immersion objective.
Quantitative Determination of IFN-γ Serum Level Using Sandwich Enzyme Immunoassay Technique
This assay employs the quantitative sandwich enzyme immunoassay technique. A polyclonal antibody specific for human IFN-γ (R&D system a biotechne brand catalog number DIF50, USA) was used following manufacturer instructions and was done in ELISA system (biotek, USA). Briefly, a polyclonal antibody specific for human IFN-γ had been pre-coated onto a microplate. Standards and samples were pipetted into the wells and any IFN-γ present was bound by the immobilized antibody. After washing away any unbound substances, an enzyme-linked polyclonal antibody specific for human IFN-γ was added to the wells. Following a wash to remove any unbound antibody-enzyme reagent, a substrate solution was added to the wells and color develops in proportion to the amount of IFN-γ bound in the initial step. The color development was stopped and the intensity of the color was measured. The optical density of each well was determined after within 30 min by using a microplate reader set to 450 nm, Fig.1 .
Concentration of IFN-γ (pg/ml) Figure 1. Standard curve of IFN-ɣ concentration

Determination of DNA Methylation Patterns of IFN-γ Gene Promoter Using MS-PCR
DNA Extraction
Genomic DNA was extracted from PB samples using QIAamp DNA Mini kit(Qiagen, USA) following manufacturer instructions. Purity and concentration of DNA samples were measured using spectrophotometer (Apel303uv-Japan).
Sodium Bisulfate Modification
DNA methylation status was modified using sodium bisulfite modification kit (Qiagen, USA) following manufacturer instructions which includes incubation of the target DNA with sodium bisulfite to convert un-methylated cytosine into uracil while it leaves the methylated cytosines unchanged. Therefore, bisulfite treatment gives differences between methylated DNA sequences and un-methylated DNA sequences.
Methylation Specific PCR (MS-PCR) for Detection of DNA Methylation Patterns of IFN-γ Gene Promoter
Methylation patterns of IFN-γ gene promoter was detected in modified DNA samples included in the present study using MS-PCR (12) .Two primer sets, one for methylated state and the other for non-methylated state of IFN-γ gene promoter were used. The amplified products were electrophoresed separately on 2% agarose gel. Presence of band with 154 bp means presence of methylated state, while the presence of band with 156 bp by using the primer for detection of unmethylation of IFN-γ gene promoter means there was no methylation. If both of the above bands were presented, that means partial methylation of IFN-γ gene promoter.
Thermal cycler (LABNET,USA) was used. Optimization of reaction conditions was done by using different concentration of primers (1µl, 1.5µl and 2µl), different concentrations of DNA were (2µl,3 µl, and 5 µl) and gradient annealing temperature was from (48-69)°C.
Determination of Serum INF-γ Level
Receiver operating characteristics (ROC) curves were applied to compare the performance of the biochemical prognostic methods of disease and to determine the appropriate cut off values of serum IFN-γ level in TB patient compared with normal control by using 59.3 pg/ml as cut-off value. The optimal cut-off value for serum IFN-γ level in all groups estimated from ROC curves, according to these results, test is considered positive if test is > threshold value (cut off values).
Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated to analyze the prognostic value of serum INF-γ level and they were 75.5%, 60%, 79.4% and 55.6%,respictivly.
Statistical Analysis:
Chi-square test used to compare frequency. Chi-square test was performed for methylation and un-methylation of IFN-γ gene promoter to determine the significant of the test (15) .
Results: Serum IFN-γ Level
Serum IFN-γ level was measured to evaluate its usefulness in prognosis and follow up of patients with TB disease. The bio-statistical calculation and studies ttest were done by using SPSS program (version 22) for IFN-γ level in sera of normal controls, newly diagnostic TB patients and relapse TB patients. The Serum IFN-γ level from both newly diagnose TB patients and relapse TB patients were high significantly increased (P<0.001 and 0.014, respectively) when compared to normal controls.
Determination of DNA Methylation Patterns of IFN-γ Gene Promoter Using Methylation Specific-PCR (MSP)
The analyses of the differentially DNA methylated patterns of IFN-γ gene promoter were compared between patients with active TB disease and normal controls subjects or between relapsed TB patients and normal controls subjects. Methylation specific-PCR results of IFN-γ gene promoter of included patients and controls showed in Table 2 . Agarose gel electrophoresis of MSP-PCR amplified products in different studied groups were shown in Fig. 2 . Samples were defined as methylated and unmethylated depending upon the visual band that amplified using primer set to detect methylated (M) or un-methylated (U) sites. Chi-Square test and P-Value for DNA methylated patterns of IFN-γ gene promoter in normal controls, newly diagnose TB patients and relapse TB patients were calculated. It showed high significant increase (P≤0.002 and P≤0.001, respectively) for DNA methylated patterns of IFN-γ gene promoter in normal controls, newly diagnostic TB patients and relapse TB patients. Also, it showed high significant increase (P≤0.0001 and   156  154   100   200   NTC M1  M2  M3 M4 M5  L  NTC  U1  U2  U3  U4  U5 P≤0.0001, respectively) for DNA un-methylated pattern of IFN-γ gene promoter in normal controls, newly diagnostic TB patients and relapse TB patients. That referred to the possibility of use DNA methylation patterns of IFN-γ gene promoter as prognostic marker in TB patients.
Discussion: Serum IFN-γ level
A number of signaling pathways control the initial infection of the macrophages with the bacteria elevates the host inflammatory response (16) . Pro-inflammatory cytokines including IFN-γ are produced from activated macrophages as response to toll like receptor-2(TLR-2) signaling pathway. In active tuberculosis, serum levels of these mediators and IFN-γ levels have been proved high in patients (11) .Interferon gamma is one of the most important pro-inflammatory cytokines in many infectious or noninfectious chronic inflammatory diseases, and whole blood IFNassays are popular in diagnosis of human tuberculosis (17, 18, 19 ). In the current study, the results revealed highly significant elevation in serum IFN-γ level (Table 1) in newly diagnostic TB patients, relapse TB patients and healthy controls (P<0.001and P<0.014, respectively). These results are consistent with previous studies showing elevated plasma levels of IFN-in newly diagnosed TB patients and relapse TB patients suggesting up-regulation in the proinflammatory response (18, 19) .
The criteria of diagnosis validity (sensitivity, specificity, positive predictability, negative predictability and efficiency tests) of serum IFN-γ level in TB patients compared to that of healthy controls, using 59.3 pg/ml as cut-off value (clinical decision),were 75.5%, 60%, 79.4%, 55.4%,and 70.7%, respectively. The fact that serum IFN-γ levels are up-regulated in the newly diagnosed TB patients indicates innate protective response during early phase of M. tuberculosis infection. The results of the current study agree with previous studies (19) (20) (21) (22) (23) .These findings could be referred to possibility of developing immune-prognostic assays based on new biomarkers detection.
DNA Methylation Pattern of IFN-γ Gene Promoter
Mycobacterium tuberculosis may be drip the bactericidal effects of phagosomes multiply and survive in the infected host cells through activating an anti-inflammatory response and struggling acidification of the phagosomes by enhancing an adaptive response with T-cell activation and further triggering of macrophages and neutrophil accumulation to form granulomas leading to latent infections (LTBI) that may become active tuberculosis only as the host's immune response fails (11, 24) .
Mycobacteria can alter the methylation of host gene to modify the host immune system situations (25) .The dynamic nature of the epigenome enable cells to translate environmental signals to appropriate response by modifying its transcriptional machinery (26, 27) . Modification in DNA methylation during M. tuberculosis infection was seen across the whole macrophage genome. It was referred to correlation between methylation status of gene body(the rest of gene sequences other than promoter sequence) gene regulation but most studies showed a strong association of gene promoter methylation with gene transcription (28) . However, DNA methylation modifications upon M. tuberculosis infection mostly associated with nonpromoter, non-exonic regions of the genome. Tissue-specific-methylated non-promoter regions are cis-regulatory elements like enhancers, transcriptional activators or repressors, so, regulatory regions were targeted by M. tuberculosis during infection of macrophages and that finding was also confirmed by several non-coding RNA genes, which have role in the regulation of gene expression, were the targets of infection agents induced DNA methylation modification (25, (29) (30) (31) ).
In the current study, percentages of DNA methylation, partial methylation, and un-methylated patterns of IFN-γ gene promoter were determined in different studied groups. In the health controls, 63.5% of the samples showed total methylation of IFN-γ gene promoter, 9.5% showed un-methylated of IFN-γ gene promoter and 27% showed partial methylation. In newly diagnostic TB patients, 18.2% of the samples showed total methylation of IFN-γ gene promoter,39.4% positive for unmethylated of IFN-γ gene promoter and 42.4% showed partial methylation of IFN-γ gene promoter and in relapse TB patients, 21.2% of the samples showed total methylation of IFN-γ gene promoter,51.5% positive un-methylated of IFN-γ gene promoter and 27.3% showed partial methylation. The results tend to decrease in methylation or hypo-methylation in IFN-γ gene promoter in patients with TB and increase in unmethylation form. These are consider of switch on of DNA expression for IFN-γ gene promoter.
There are confirmed information regarding DNA methylation of IFN-γ promoter, but investigation of status of other relevant sequences for IFN-gene expression in lymphocytes need more studies. Also, the role of other epigenetic marks, such as histone modifications and micro-RNA, in pathogenesis patterns of M. tuberculosis need to be investigated. 
